Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet? (Q35801931)

10 August 2017

Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet? (English)

1 reference

inflammatory bowel diseases

10 August 2017

0 references

Daniela Elena Serban

1

0 references

language of work or name

1 reference

9 October 2015

1 reference

Nutrition in Clinical Practice

10 August 2017

1 reference

10 August 2017

30

1 reference

10 August 2017

6

1 reference

10 August 2017

760-779

1 reference

Therapeutic Manipulation of the Microbiome in IBD: Current Results and Future Approaches

10 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

The genetics of Crohn's disease and ulcerative colitis--status quo and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Epidemiology and natural history of inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Antibiotics associated with increased risk of new-onset Crohn's disease but not ulcerative colitis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Contribution of genetic and environmental factors in the pathogenesis of Crohn's disease in a large family with multiple cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Inflammatory bowel disease in immigrants to Canada and their children: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

A human gut microbial gene catalogue established by metagenomic sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

A framework for human microbiome research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

The gut microbiome in health and in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

An integrated catalog of reference genes in the human gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

The intestinal microbiota in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Gastrointestinal cancers: influence of gut microbiota, probiotics and prebiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

The intestinal microbiota in inflammatory bowel diseases: time to connect with the host

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Diversity, stability and resilience of the human gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

The treatment-naive microbiome in new-onset Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

The microbiome in inflammatory bowel disease: current status and the future ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Role of genetics in pediatric inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

The microbiota in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Beyond gene discovery in inflammatory bowel disease: the emerging role of epigenetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Complex host genetics influence the microbiome in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

IBD: microbiota manipulation through diet and modified bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Nutrigenetics, nutrigenomics and inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Reprograming of gut microbiome energy metabolism by the FUT2 Crohn's disease risk polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Genome-wide methylation profiling in Crohn's disease identifies altered epigenetic regulation of key host defense mechanisms including the Th17 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Two-stage genome-wide methylation profiling in childhood-onset Crohn's Disease implicates epigenetic alterations at the VMP1/MIR21 and HLA loci.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Implication of miRNAs for inflammatory bowel disease treatment: Systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Crohn's disease-associated adherent invasive Escherichia coli modulate levels of microRNAs in intestinal epithelial cells to reduce autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Enteral nutrition as treatment option for Crohn's disease: in kids only?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Effects of enteral nutrition on Crohn's disease: clues to the impact of diet on disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Characterization of the gastrointestinal microbiota in health and inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Gut microbiome in new-onset Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

IBD. Specific genetic and microbial signature associated with paediatric ileal Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Detection and isolation of Campylobacter species other than C. jejuni from children with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

The microaerophilic microbiota of de-novo paediatric inflammatory bowel disease: the BISCUIT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Microbiota of de-novo pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Microbiota separation and C-reactive protein elevation in treatment-naïve pediatric granulomatous Crohn disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Fecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Microbial dysbiosis in pediatric patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Campylobacter concisus and other Campylobacter species in children with newly diagnosed Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Mucosal bacterial microflora and mucus layer thickness in adolescents with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Low counts of Faecalibacterium prausnitzii in colitis microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Molecular analysis of the gut microbiota of identical twins with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Comparative metagenomics and population dynamics of the gut microbiota in mother and infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Molecular diversity of Escherichia coli in the human gut: new ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Characterization of adherent-invasive Escherichia coli isolated from pediatric patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Characterization of Escherichia coli isolated from gut biopsies of newly diagnosed patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Crohn's disease-associated Escherichia coli survive in macrophages by suppressing NFκB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

α-Haemolysin of Escherichia coli in IBD: a potentiator of inflammatory activity in the colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Replication of Crohn's disease-associated AIEC within macrophages is dependent on TNF-α secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Defective macrophage handling of Escherichia coli in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Prevalence of Campylobacter species in adult Crohn's disease and the preferential colonization sites of Campylobacter species in the human intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Detection of Campylobacter concisus and other Campylobacter species in colonic biopsies from adults with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Campylobacter concisus and inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Host attachment, invasion, and stimulation of proinflammatory cytokines by Campylobacter concisus and other non-Campylobacter jejuni Campylobacter species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Dysbiosis in inflammatory bowel diseases: the oxygen hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Association between specific mucosa-associated microbiota in Crohn's disease at the time of resection and subsequent disease recurrence: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Role of intestinal bacteria in the pathogenesis of pouchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Dysbiosis in pouchitis: evidence of unique microfloral patterns in pouch inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Distinct microbiome in pouchitis compared to healthy pouches in ulcerative colitis and familial adenomatous polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Characterization of the gut-associated microbiome in inflammatory pouch complications following ileal pouch-anal anastomosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Correlations between colonic crypt mucin chemotype, inflammatory grade and Desulfovibrio species in ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

The role of Klebsiella in Crohn's disease with a potential for the use of antimicrobial measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Enterohepatic helicobacter in ulcerative colitis: potential pathogenic entities?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Burdening questions about Clostridium difficile in pediatric inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Clostridium difficile infection in newly diagnosed pediatric inflammatory bowel disease in the mid-southern United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Clostridium difficile and pediatric inflammatory bowel disease: a prospective, comparative, multicenter, ESPGHAN study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Review article: cytomegalovirus and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Integrated metagenomics/metaproteomics reveals human host-microbiota signatures of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Metabolic alterations to the mucosal microbiota in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Metabolomics reveals metabolic biomarkers of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Metabolism of the colonic mucosa in patients with inflammatory bowel diseases: an in vitro proton magnetic resonance spectroscopy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Metabonomics in ulcerative colitis: diagnostics, biomarker identification, and insight into the pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Impaired innate immune function associated with fecal supernatant from Crohn's disease patients: insights into potential pathogenic role of the microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Bacteriophages in gut samples from pediatric Crohn's disease patients: metagenomic analysis using 454 pyrosequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Study of the viral and microbial communities associated with Crohn's disease: a metagenomic approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Disease-specific alterations in the enteric virome in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Decoding norovirus infection in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Fungi and inflammatory bowel diseases: Alterations of composition and diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

The fungal microbiota of de-novo paediatric inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Consumption of vegetables and fruit and the risk of inflammatory bowel disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Combinatorial effects of diet and genetics on inflammatory bowel disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Dietary clues to the pathogenesis of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Translocation of Crohn's disease Escherichia coli across M-cells: contrasting effects of soluble plant fibres and emulsifiers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Bacterial overgrowth and inflammation of small intestine after carboxymethylcellulose ingestion in genetically susceptible mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Deregulation of intestinal anti-microbial defense by the dietary additive, maltodextrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Western diet induces dysbiosis with increased E coli in CEABAC10 mice, alters host barrier function favouring AIEC colonisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Environmental factors in the relapse and recurrence of inflammatory bowel disease: a review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Review article: vitamin D and inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Linking long-term dietary patterns with gut microbial enterotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Use of exclusive enteral nutrition in adults with Crohn's disease: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Treatment of IBD: where we are and where we are going

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Effect of exclusive enteral nutrition on gut microflora function in children with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Decline in presumptively protective gut bacterial species and metabolites are paradoxically associated with disease improvement in pediatric Crohn's disease during enteral nutrition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Effect of exclusive enteral nutrition on the microbiota of children with newly diagnosed Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Prevalence of a gluten-free diet and improvement of clinical symptoms in patients with inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Clinical trial: vitamin D3 treatment in Crohn's disease - a randomized double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn's disease: Results from a randomised double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Diet in the pathogenesis and treatment of inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Antibiotics, probiotics and prebiotics in IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Probiotics and antibiotics in IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Probiotic Mix VSL#3 Is Effective Adjunctive Therapy for Mild to Moderately Active Ulcerative Colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Recommendations for probiotic use in humans-a 2014 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

High-dose probiotics for the treatment of active pouchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Outcome of four weeks' intervention with probiotics on symptoms and endoscopic appearance after surgical reconstruction with a J-configurated ileal-pouch-anal-anastomosis in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Prebiotic effects: metabolic and health benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Treatment of ulcerative colitis with germinated barley foodstuff feeding: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Bifidogenic growth stimulator for the treatment of active ulcerative colitis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Effect of dietary inulin supplementation on inflammation of pouch mucosa in patients with an ileal pouch-anal anastomosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Metabolic profiling of the impact of oligofructose-enriched inulin in Crohn's disease patients: a double-blinded randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Effect of oligofructose-enriched inulin (OF-IN) on bacterial composition and disease activity of patients with Crohn's disease: results from a double-blinded randomised controlled trial: Table 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

A randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

High dose probiotic and prebiotic cotherapy for remission induction of active Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Meta-analysis of broad-spectrum antibiotic therapy in patients with active inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Use of antibiotics in patients with Crohn's disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Newly developed antibiotic combination therapy for ulcerative colitis: a double-blind placebo-controlled multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Fecal Microbiota Transplantation for Ulcerative Colitis: Not Just Yet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Fecal transplant: a safe and sustainable clinical therapy for restoring intestinal microbial balance in human disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Helminth therapy (worms) for induction of remission in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Mucosal barrier, bacteria and inflammatory bowel disease: possibilities for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Serine protease inhibitors protect better than IL-10 and TGF-β anti-inflammatory cytokines against mouse colitis when delivered by recombinant lactococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Review article: selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Inhibition of HDAC9 increases T regulatory cell function and prevents colitis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

New serological markers in pediatric patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Novel Anti-Glycan Antibodies Related to Inflammatory Bowel Disease Diagnosis and Phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Increased immune reactivity predicts aggressive complicating Crohn's disease in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Age of diagnosis influences serologic responses in children with Crohn's disease: a possible clue to etiology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Specificities of the fecal microbiota in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Dysbiosis in inflammatory bowel disease: a role for bacteriophages?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

Differential clustering of bowel biopsy-associated bacterial profiles of specimens collected in Mexico and Canada: what do these profiles represent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533615606898

21 January 2018

Identifiers

DOI

10.1177/0884533615606898

1 reference

10 August 2017

1 reference

PubMed ID

26452390